|
FDA Seeking Stakeholder Input on Postapproval Study Designs
Companies could get a better idea of what the FDA expects in postapproval studies (PAS) required as part of a device’s approval at an Aug. 30 agency workshop.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives